首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators
【24h】

Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators

机译:癌症的分子起源:儿茶酚雌激素-3,4-醌是内源性肿瘤引发剂

获取原文
获取原文并翻译 | 示例
           

摘要

Cancer is a disease that begins with mutation of critical genes: oncogenes and tumor suppressor genes. Our research on carcinogenic aromatic hydrocarbons indicates that depurinating hydrocarbon-DNA adducts generate oncogenic mutations found in mouse skin papillomas (Proc. Natl. Acad. Sci. USA 92:10422, 1995). These mutations arise by mis-replication of unrepaired apurinic sites derived from the loss of depurinating adducts. This relationship led us to postulate that oxidation of the carcinogenic 4-hydroxy catechol estrogens (CE) of estrone (E1) and estradiol (E_2) to catechol estrogen-3,4-quinones (CE-3, 4-Q) results in electrophilic intermediates that covalently bind to DNA to form depurinating adducts.
机译:癌症是一种从关键基因突变开始的疾病:致癌基因和抑癌基因。我们对致癌性芳烃的研究表明,脱嘌呤的烃-DNA加合物产生了在小鼠皮肤乳头状瘤中发现的致癌突变(美国国家科学院院刊92:10422,1995)。这些突变是由于未纯化的嘌呤位点的错误复制而引起的,而这些位点是由去嘌呤加合物的丢失引起的。这种关系使我们推测雌激素(E1)和雌二醇(E_2)的致癌性4-羟基邻苯二酚雌激素(CE)氧化为邻苯二酚雌激素-3,4-醌(CE-3,4-Q)会导致亲电与DNA共价形成脱嘌呤加合物的中间体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号